Events Calendar

Mon
Tue
Wed
Thu
Fri
Sat
Sun
M
T
W
T
F
S
S
30
31
1
12:00 AM - TEDMED 2017
2
3
5
6
7
8
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
30
1
2
3
TEDMED 2017
2017-11-01 - 2017-11-03    
All Day
A healthy society is everyone’s business. That’s why TEDMED speakers are thought leaders and accomplished individuals from every sector of society, both inside and outside [...]
AMIA 2017 Annual Symposium
2017-11-04 - 2017-11-08    
All Day
Call for Participation We invite you to contribute your best work for presentation at the AMIA Annual Symposium – the foremost symposium for the science [...]
Beverly Hills Health IT Summit
2017-11-09 - 2017-11-10    
All Day
About Health IT Summits U.S. healthcare is at an inflection point right now, as policy mandates and internal healthcare system reform begin to take hold, [...]
Forbes Healthcare Summit
2017-11-29 - 2017-11-30    
All Day
ForbesLive leverages unique access to the world’s most influential leaders, policy-makers, entrepreneurs, and artists—uniting these global forces to harness their collective knowledge, address today’s critical [...]
Events on 2017-11-01
TEDMED 2017
1 Nov 17
La Quinta
Events on 2017-11-04
AMIA 2017 Annual Symposium
4 Nov 17
WASHINGTON
Events on 2017-11-09
Beverly Hills Health IT Summit
9 Nov 17
Los Angeles
Events on 2017-11-29
Forbes Healthcare Summit
29 Nov 17
New York
Articles

Amyotrophic lateral sclerosis (ALS) Industry 2020 Rapidly Growing with High Revenue

amyotrophic lateral scelrosis

Amyotrophic lateral sclerosis (ALS) Industry 2020 Rapidly Growing with High Revenue

Amyotrophic lateral sclerosis (ALS) belongs to a group of neurological disease. Otherwise called motor neuron diseases, they influence the engine elements of voluntary muscles in the body. Factors, for example, an expansion in the occurrence rate of ALS, grow in the awareness about the ailment among patients, and ascend in the geriatric populace is relied upon to help the development of the amyotrophic lateral sclerosis market. Other factors including the tendency towards the stationary way of life are driving the market development and expanding the danger of getting attacked by ALS.

Furthermore, the expanding geriatric populace substantiates market development, making interest in symptomatic and focused on treatment alternatives. However, the staggering expense of the treatment of ALS may impede market development over the figure time frame.

The Amyotrophic lateral sclerosis market is growing at 7.89 % CAGR and is expected to reach the valuation of USD 841.6 million by the year 2023.

Major players

Mylan N.V. (U.S.), Covis Pharma (Switzerland), Ionis Pharmaceutical (U.S.), ITF Pharma (U.S.), Ascend Pharmaceuticals LLC (U.S.), Apotex Inc. (Canada), Sun Pharmaceutical (India), Mitsubishi Tanabe Pharma America (U.S.), Biogen (U.S.), Sanofi (France), among others are some of the major players in the Global amyotrophic lateral sclerosis market.

The Global amyotrophic lateral sclerosis market has been classified on the basis of its treatment, type, end-user, and regional demand. Based on its type, the market is classified into familial ALS and sporadic. Based on its treatment, the market has been segmented into physical therapy, speech therapy, medication, respiratory therapy, and others. By its end-user, the ALS market has been segmented into research & academic institutes, specialty centers, hospitals, and others.

Source inforgrowth.com/report/1850367/amyotrophic-lateral-sclerosis-market

About InForGrowth

At InForGrowth, Understand Research requirements and help a client in taking informed business critical decisions. Given the complexities and interdependencies of market-intelligence, there is always more than one source to explore and arrive at the right answer. Through our smart search feature and our reliable and trusted publishing partners, we are paving way for a more simplified and relevant research.